COMPANY

Cerebriu
Healthcare technology company based in Copenhagen, Denmark
Founded 2018Copenhagen, Denmark
Product: Cerebriu Apollo Brain Company: Cerebriu
European Radiology, 2025
To assess the prevalence of motion artifacts and the factors associated with them in a cohort of suspected stroke patients, and to determine their impact on diagnostic accuracy for both AI and radiologists.
This retrospective cross-sectional study included brain MRI scans of consecutive adult suspected stroke patients from a non-comprehensive Danish stroke center between January and April 2020. An expert neuroradiologist identified acute ischemic, hemorrhagic, and space-occupying lesions as references. Two blinded radiology residents rated MRI image quality and motion artifacts. The diagnostic accuracy of a CE-marked deep learning tool was compared to that of radiology reports. Multivariate analysis examined associations between patient characteristics and motion artifacts.
775 patients (68 years ± 16, 420 female) were included. Acute ischemic, hemorrhagic, and space-occupying lesions were found in 216 (27.9%), 12 (1.5%), and 20 (2.6%). Motion artifacts were present in 57 (7.4%). Increasing age (OR per decade, 1.60; 95% CI: 1.26, 2.09; p < 0.001) and limb motor symptoms (OR, 2.36; 95% CI: 1.32, 4.20; p = 0.003) were independently associated with motion artifacts in multivariate analysis. Motion artifacts significantly reduced the accuracy of detecting hemorrhage. This reduction was greater for the AI tool (from 88 to 67%; p < 0.001) than for radiology reports (from 100 to 93%; p < 0.001). Ischemic and space-occupying lesion detection was not significantly affected.
Motion artifacts are common in suspected stroke patients, particularly in the elderly and patients with motor symptoms, reducing accuracy for hemorrhage detection by both AI and radiologists.